Green tea polyphenol (-)-epigallocatechin-3-gallate (egcg): a time for a new player in the treatment of respiratory diseases?

HIGHLIGHTS

• who: Daniela Mokra and collaborators from the Department of Physiology, Jessenius Faculty of Medicine in, Comenius University in Bratislava have published the research work: Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG): A Time for a New Player in the Treatment of Respiratory Diseases?, in the Journal: Antioxidants 2022, 11, 1566. of /2022/
• what: For the review, articles in English language from the PubMed database were used. Results from this model showed that EGCG prevented a bleomycin-induced increase in generation of ROS, restored a decrease in antioxidant status, and enhanced Nrf2 activity.
• how . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.